These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 17701596

  • 1. Rituximab for treatment of chemoimmunotherapy naive marginal zone lymphoma.
    Lossos IS, Morgensztern D, Blaya M, Alencar A, Pereira D, Rosenblatt J.
    Leuk Lymphoma; 2007 Aug; 48(8):1630-2. PubMed ID: 17701596
    [No Abstract] [Full Text] [Related]

  • 2. Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone.
    Tsimberidou AM, Catovsky D, Schlette E, O'Brien S, Wierda WG, Kantarjian H, Garcia-Manero G, Wen S, Do KA, Lerner S, Keating MJ.
    Cancer; 2006 Jul 01; 107(1):125-35. PubMed ID: 16700034
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of splenic marginal zone lymphoma: splenectomy versus rituximab.
    Bennett M, Schechter GP.
    Semin Hematol; 2010 Apr 01; 47(2):143-7. PubMed ID: 20350661
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Re: Rituximab monotherapy is highly effective in splenic marginal zone lymphoma.
    Bennett M, Yegena S, Dave HP, Schechter GP.
    Hematol Oncol; 2008 Jun 01; 26(2):114. PubMed ID: 18271062
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Severe pulmonary complications after initial treatment with Rituximab for the Asian-variant of intravascular lymphoma.
    Wu SJ, Chou WC, Ko BS, Tien HF.
    Haematologica; 2007 Jan 01; 92(1):141-2. PubMed ID: 17229654
    [Abstract] [Full Text] [Related]

  • 9. Refractory cold agglutinin-immunohaemolytic anaemia associated to marginal zone lymphoma responding to rituximab.
    Petit J, Clavo M, de Sevilla AF, González-Barca E, Domingo-Doménech E, Grañena A.
    Hematol J; 2003 Jan 01; 4(6):450-1. PubMed ID: 14671620
    [Abstract] [Full Text] [Related]

  • 10. Splenic marginal zone lymphoma, iliac vein thrombosis, and monoclonal immunoglobulin Mkappa antiphospholipid antibody with Annexin A5 interaction.
    Martin SE, Abel RF.
    Leuk Lymphoma; 2006 Sep 01; 47(9):1994-6. PubMed ID: 17065025
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma.
    Else M, Marín-Niebla A, de la Cruz F, Batty P, Ríos E, Dearden CE, Catovsky D, Matutes E.
    Br J Haematol; 2012 Nov 01; 159(3):322-8. PubMed ID: 23016878
    [Abstract] [Full Text] [Related]

  • 13. Rituximab for bone lymphoma.
    Savage DG, Staron R.
    Ann Intern Med; 2001 Jun 19; 134(12):1156-7. PubMed ID: 11412072
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunophenotypic changes and clinical outcome in B-cell lymphomas treated with rituximab.
    Seliem RM, Freeman JK, Steingart RH, Hasserjian RP.
    Appl Immunohistochem Mol Morphol; 2006 Mar 19; 14(1):18-23. PubMed ID: 16540725
    [Abstract] [Full Text] [Related]

  • 16. Successful treatment of catastrophic antiphospholipid antibody syndrome (CAPS) associated with splenic marginal-zone lymphoma with low-molecular weight heparin, rituximab and bendamustine.
    Manner H, Jung B, Tonassi L, Hackenberg U, Plum N, Josten KM, Kirchmaier CM, Frickhofen N.
    Am J Med Sci; 2008 May 19; 335(5):394-7. PubMed ID: 18480659
    [Abstract] [Full Text] [Related]

  • 17. Antilymphoma effects of anti-HLA-DR and CD20 monoclonal antibodies (Lym-1 and Rituximab) on human lymphoma cells.
    Liu C, DeNardo G, Tobin E, DeNardo S.
    Cancer Biother Radiopharm; 2004 Oct 19; 19(5):545-61. PubMed ID: 15650447
    [Abstract] [Full Text] [Related]

  • 18. Rituximab as first line treatment for MALT lymphoma of extraocular muscles.
    Benetatos L, Alymara V, Asproudis I, Bourantas KL.
    Ann Hematol; 2006 Sep 19; 85(9):625-6. PubMed ID: 16691396
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical observation of Rituximab in a CD20+B non-Hodgkin's lymphoma].
    Hao LC, Zhang LZ.
    Zhonghua Er Ke Za Zhi; 2003 Aug 19; 41(8):627. PubMed ID: 14744396
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.